The Enterprise Value as of December 2025 (TTM) for Regencell Bioscience Holdings Limited (RGC) is 7.91B

According to Regencell Bioscience Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 7.91B. This represents a change of 6.62% compared to the average of 117.78M of the last 4 quarters.

Regencell Bioscience Holdings Limited (RGC) Historical Enterprise Value (quarterly & annually)

How has RGC Enterprise Value performed in the past?

The mean historical Enterprise Value of Regencell Bioscience Holdings Limited over the last ten years is 198.10M. The current 7.91B Enterprise Value has changed 399.29% with respect to the historical average. Over the past ten years (40 quarters), RGC's Enterprise Value was at its highest in in the June 2022 quarter at 444.60M. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.65M.

Regencell Bioscience Holdings Limited (RGC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Regencell Bioscience Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Regencell Bioscience Holdings Limited (RGC) Average Enterprise Value

How has RGC Enterprise Value performed in the past?

The current Enterprise Value of Regencell Bioscience Holdings Limited (RGC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Regencell Bioscience Holdings Limited (RGC) Enterprise Value vs. Peers

How is RGC’s Enterprise Value compared to its peers?

Regencell Bioscience Holdings Limited’s Enterprise Value is less than Cytokinetics, Incorporated (8.73B), greater than Merus N.V. (6.93B), less than AptarGroup, Inc. (8.69B), less than Grifols, S.A. (15.64B), greater than Abivax S.A. (7.28B), greater than Rhythm Pharmaceuticals, Inc. (7.15B), greater than Stevanato Group S.p.A. (5.71B), greater than Axsome Therapeutics, Inc. (7.35B), greater than Nuvalent, Inc. (7.65B), less than Masimo Corporation (7.93B),

Build a custom stock screener for Regencell Bioscience Holdings Limited (RGC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regencell Bioscience Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Regencell Bioscience Holdings Limited (RGC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Regencell Bioscience Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.